These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 26069821)

  • 1. Magnesium and outcomes in patients with chronic kidney disease: focus on vascular calcification, atherosclerosis and survival.
    Massy ZA; Drüeke TB
    Clin Kidney J; 2012 Feb; 5(Suppl 1):i52-i61. PubMed ID: 26069821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between magnesium and clinical biomarkers on inhibition of vascular calcification.
    Salem S; Bruck H; Bahlmann FH; Peter M; Passlick-Deetjen J; Kretschmer A; Steppan S; Volsek M; Kribben A; Nierhaus M; Jankowski V; Zidek W; Jankowski J
    Am J Nephrol; 2012; 35(1):31-9. PubMed ID: 22179063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low Magnesium Levels and FGF-23 Dysregulation Predict Mitral Valve Calcification as well as Intima Media Thickness in Predialysis Diabetic Patients.
    Silva AP; Gundlach K; Büchel J; Jerónimo T; Fragoso A; Silva C; Guilherme P; Santos N; Faísca M; Neves P
    Int J Endocrinol; 2015; 2015():308190. PubMed ID: 26089881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnesium and cardiovascular complications of chronic kidney disease.
    Massy ZA; Drüeke TB
    Nat Rev Nephrol; 2015 Jul; 11(7):432-42. PubMed ID: 25963594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valvular calcification and its relationship to atherosclerosis in chronic kidney disease.
    Leskinen Y; Paana T; Saha H; Groundstroem K; Lehtimäki T; Kilpinen S; Huhtala H; Airaksinen J
    J Heart Valve Dis; 2009 Jul; 18(4):429-38. PubMed ID: 19852148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Magnesium disorder and its clinical significance in chronic kidney disease].
    Okuno S
    Clin Calcium; 2012 Aug; 22(8):1243-9. PubMed ID: 22846361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated Circulating Osteoprotegerin Levels in the Plasma of Hemodialyzed Patients With Severe Artery Calcification.
    Krzanowski M; Krzanowska K; Dumnicka P; Gajda M; Woziwodzka K; Fedak D; Grodzicki T; Litwin JA; Sułowicz W
    Ther Apher Dial; 2018 Oct; 22(5):519-529. PubMed ID: 29974642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnesium and calciprotein particles in vascular calcification: the good cop and the bad cop.
    Zeper LW; de Baaij JHF
    Curr Opin Nephrol Hypertens; 2019 Jul; 28(4):368-374. PubMed ID: 31045659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum magnesium level and vascular stiffness in children with chronic kidney disease on regular hemodialysis.
    Zaher MM; Abdel-Salam M; Abdel-Salam R; Sabour R; Morsy AA; Gamal D
    Saudi J Kidney Dis Transpl; 2016 Mar; 27(2):233-40. PubMed ID: 26997375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnesium Administration in Chronic Kidney Disease.
    Vermeulen EA; Vervloet MG
    Nutrients; 2023 Jan; 15(3):. PubMed ID: 36771254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnesium as a Calcification Inhibitor.
    Hénaut L; Massy ZA
    Adv Chronic Kidney Dis; 2018 May; 25(3):281-290. PubMed ID: 29793668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnesium - its role in CKD.
    M de Francisco AL; Rodríguez M
    Nefrologia; 2013; 33(3):389-99. PubMed ID: 23640095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of magnesium supplementation on vascular calcification in chronic kidney disease-a randomised clinical trial (MAGiCAL-CKD): essential study design and rationale.
    Bressendorff I; Hansen D; Schou M; Kragelund C; Brandi L
    BMJ Open; 2017 Jun; 7(6):e016795. PubMed ID: 28645983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Magnesium on the Phosphate Toxicity in Chronic Kidney Disease: Time for Intervention Studies.
    Sakaguchi Y; Hamano T; Isaka Y
    Nutrients; 2017 Feb; 9(2):. PubMed ID: 28178182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The emerging role of magnesium in CKD.
    Sakaguchi Y
    Clin Exp Nephrol; 2022 May; 26(5):379-384. PubMed ID: 35076791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examining the effects of uric acid-lowering on markers vascular of calcification and CKD-MBD; A post-hoc analysis of a randomized clinical trial.
    Andrews ES; Perrenoud L; Nowak KL; You Z; Pasch A; Chonchol M; Kendrick J; Jalal D
    PLoS One; 2018; 13(10):e0205831. PubMed ID: 30356327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnesium in chronic kidney disease: challenges and opportunities.
    Kanbay M; Goldsmith D; Uyar ME; Turgut F; Covic A
    Blood Purif; 2010; 29(3):280-92. PubMed ID: 20090315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnesium but not nicotinamide prevents vascular calcification in experimental uraemia.
    Kaesler N; Goettsch C; Weis D; Schurgers L; Hellmann B; Floege J; Kramann R
    Nephrol Dial Transplant; 2020 Jan; 35(1):65-73. PubMed ID: 30715488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are there ways to attenuate arterial calcification and improve cardiovascular outcomes in chronic kidney disease?
    Vo TM; Disthabanchong S
    World J Cardiol; 2014 May; 6(5):216-26. PubMed ID: 24944752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CKD, arterial calcification, atherosclerosis and bone health: Inter-relationships and controversies.
    Reiss AB; Miyawaki N; Moon J; Kasselman LJ; Voloshyna I; D'Avino R; De Leon J
    Atherosclerosis; 2018 Nov; 278():49-59. PubMed ID: 30253289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.